Global Drug Screening Market, By Product and Services (Equipment, Analytical Instruments, Rapid Testing Devices (RTD), Consumables, Drug screening, Analytical Instruments, and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers, Individual Users, Colleges) – Industry Trends and Forecast to 2031.
Drug Screening Market Analysis and Size
In sports and athletics, drug screening market serves as a critical tool to uphold fairness, integrity, and safety. Sporting organizations employ rigorous testing protocols to detect the use of performance-enhancing drugs (PEDs) or banned substances among athletes. This ensures a level playing field by deterring doping practices and maintaining the integrity of competitions. Drug screening not only promotes ethical standards but also safeguards the health and well-being of athletes, as the use of certain substances can pose serious health risks.
Global drug screening market size was valued at USD 7.30 billion in 2023 and is projected to reach USD 26.15 billion by 2031, with a CAGR of 17.30% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Drug Screening Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product and Services (Equipment, Liquid Analytical Instruments, Rapid Testing Devices (RTD), Consumables, Drug screening, Analytical Instruments, and Laboratory Services), Sample Type (Oral Fluid or Saliva, Breath, Hair, Urine, Other Samples), End User (Workplace and Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers, Individual Users, and Colleges)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
LabCorp (U.S.), Quest Diagnostics (U.S.), Abbott (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Alfa Scientific Designs, Inc. (U.S.), OraSure Technologies, Inc. (U.S.), Siemens (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (U.S.), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (U.S.), Omega Laboratories, Inc. (U.S.), Psychemedics Corporation (U.S.), Clinical Reference Laboratory Inc., (U.S.), American Bio Medica Corporation (U.S.), ACM Global Laboratories (U.S.), Sciteck, Inc. (U.S.), Synens SAS (France), Intoximeters (U.S.), AccuSource Inc., (U.S.), Cordant Health Solutions (U.S.), and Millennium Health (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Drug screening is a process used to detect the presence of drugs or their metabolites in biological samples such as urine, blood, saliva, or hair. It is commonly employed in various settings including workplaces, healthcare facilities, sports organizations, and law enforcement agencies to assess drug use or compliance with drug treatment programs.
Drug Screening Market Dynamics
Drivers
- Increased Drug and Alcohol Consumption Growing Demand for Drug Screening Measures
This rise in consumption has heightened concerns about safety, productivity, and public health, necessitating stringent screening protocols. Consequently, the drug screening market is witnessing a surge as organizations seek reliable methods to detect substance abuse among individuals. This trend is driving innovation in drug screening technologies, leading to the development of more accurate and efficient testing solutions. As a result, the drug screening market is projected to experience continued expansion in response to the escalating challenges posed by substance abuse.
According to the World Drug Report 2021 published by UNODC highlights a concerning trend with a 22% increase in global drug usage. Notably, cannabis consumption is significant, with approximately 200 million users worldwide, representing 4% of the global population. This surge in drug use underscores the urgent need for robust drug screening measures across various sectors to address health, safety, and societal implications effectively.
- Rise in Government Funding Fosters Pharmaceutical Development
Through government initiatives such as grants, subsidies, and research funding, governments incentivize drug discovery and development processes. These funds support various stages of drug screening, from early research to clinical trials, facilitating the identification of potential therapeutics. Government-backed programs often prioritize areas of public health concern, driving innovation and investment in drug screening technologies. Pharmaceutical companies and research institutions actively engage in drug screening activities to capitalize on available funding opportunities, thus stimulating the growth of the drug screening market.
Opportunities
- Rising Technological Advancements Enhances the Predictive Power of Drug Screening Processes
Recent technological advancements in drug screening, such as high-throughput screening (HTS) methods, microfluidics, and advanced imaging techniques, have revolutionized the drug screening market. These innovations allow for faster, more accurate, and cost-effective screening of potential drug candidates. The integration of artificial intelligence (AI) and machine learning algorithms further enhances the efficiency and predictive power of drug screening processes. This presents a significant opportunity for the drug screening market to expand, catering to the growing demand for novel therapeutics and personalized medicine.
- Rising Substance Abuse Issues Promotes the Adoption of Effective Drug Screening Solutions
As organizations strive to maintain safety standards and productivity in workplaces, schools, and healthcare settings, the demand for reliable drug screening methods is escalating. This presents a significant opportunity for the drug screening market to expand its offerings, catering to diverse industries with innovative testing technologies. With advancements in drug detection techniques, including rapid testing kits and sophisticated laboratory-based analyses, the market is poised for growth.
Restraints/Challenges
- Rising False Positive and Negative Results in Drug Screening limits the Screening Process
False positives occur when a test wrongly identifies a substance as present, potentially leading to unnecessary concerns or actions. Conversely, false negatives arise when a test fails to detect a substance that is actually present, posing risks of undetected drug use. These errors undermine the reliability of drug screening results, leading to diminished confidence in the screening process. Consequently, false positives may result in unwarranted consequences such as unnecessary treatment or sanctions, while false negatives could lead to overlooking substance abuse issues.
- Rise in Privacy Concerns Limits the Expansion of Drug Screening Practices
Employers and regulatory bodies face increasing scrutiny over the invasion of privacy rights through extensive drug testing practices. Heightened awareness of individual rights and data protection regulations demands more transparent and ethically sound testing methodologies, often requiring explicit consent from individuals. The fear of discrimination or stigmatization based on test results further complicates the implementation of widespread screening programs.
This drug screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2022, PhoreMost Ltd. and ThinkCyte K.K announced a strategic research partnership to advance phenotypic drug screening using artificial intelligence (AI). Combining PhoreMost's expertise in phenotypic screening with ThinkCyte's AI capabilities, the collaboration aims to accelerate drug discovery processes, potentially yielding novel therapeutics
- In April 2022, Saladax Biomedical, Inc acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV, encompassing 17 patent families. This acquisition, resulting in 33 U.S. patents and 296 international patents, strengthens Saladax's position in the field of antipsychotic drug testing, potentially leading to improved patient care
- In August 2021, Select Health of South Carolina and Quest Diagnostics collaborated to expand Select Health's laboratory network, enhancing access to diagnostic information services for Medicaid and Medicare-Medicaid dual-eligible enrollees. This partnership aims to improve healthcare outcomes by increasing members' access to vital diagnostics
- In May 2020, Psychemedics Corporation launched a Vaping Panel designed to detect Marijuana, CBD, and Nicotine usage. This innovative test fills a critical need for schools and businesses to identify drug ingestion, including through electronic cigarettes, addressing growing concerns about substance abuse
Drug Screening Market Scope
The drug screening market is segmented on the basis of product and services, sample type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Equipment
- Liquid Analytical Instruments
- Breathalyzers
- Fuel Cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Immunoassay Analyzers
- Chromatography Instruments
- Rapid Testing Devices (RTD)
- Urine Testing Devices
- Drug Testing Cups
- Dip Cards
- Drug Testing Cassettes
- Consumables
- Assay Kits
- Sample Collection Devices
- Calibrators and Controls
- Other Consumables
- Drug screening
- Liquid Analytical Instruments
- Laboratory Services
Sample Type
- Oral Fluid or Saliva
- Breath
- Hair
- Urine
- Other Samples
End User
- Workplace and Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals, Personal Users
- Pain Management Centers
- Individual Users
- Colleges
Drug Screening Market Regional Analysis/Insights
The drug screening market is analyzed, and market size insights and trends are provided by country, product and services, sample type, and end user, as referenced above.
The countries covered in the drug screening market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.
North America dominates the drug screening market due to the increasing consumption of illegal drugs in the region has led to a growing demand for drug screening services and the availability of government backing and funding to control drug abuse has facilitated the growth of the drug screening market. The rules and regulations encouraging drug screening within the region have also contributed to the market's expansion.
The Asia-Pacific region is expected to witness significant growth in workplace safety and employee well-being during the forecast period. This growth is attributed to increasing awareness of the importance of safety and health at work, as well as the commitment of governments, workers, and employers to ensure and promote a safe and healthy working environment for all workers in all workplaces. The International Labour Organization (ILO) plays a crucial role in fostering a preventative safety and health culture by strengthening national occupational safety and health (OSH) systems, including legal and policy frameworks, compliance mechanisms, occupational accident and disease reporting, awareness campaigns, and capacity building.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The drug screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug screening market. The data is available for historic period 2016-2021.
Competitive Landscape and Drug Screening Market Analysis
The drug screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the drug screening market.
Some of the major players operating in the drug screening market are:
- LabCorp (U.S.)
- Quest Diagnostics (U.S.)
- Abbott (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Alfa Scientific Designs, Inc. (U.S.)
- OraSure Technologies, Inc. (U.S.)
- Siemens (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- MPD Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Lifeloc Technologies, Inc. (U.S.)
- Drägerwerk AG & Co. KGaA (Germany)
- Premier Biotech, Inc. (U.S.)
- Omega Laboratories, Inc. (U.S.)
- Psychemedics Corporation (U.S.)
- Clinical Reference Laboratory Inc. (U.S.)
- American Bio Medica Corporation (U.S.)
- ACM Global Laboratories (U.S.)
- Sciteck, Inc. (U.S.)
- Synens SAS (France)
- Intoximeters (U.S.)
- AccuSource Inc., (U.S.)
- Cordant Health Solutions (U.S.)
- Millennium Health (U.S.)
SKU-